Dynamics of Gut Microbiota Recovery after Antibiotic Exposure in Young and Old Mice (A Pilot Study)/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Gina, Victoria

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Antimicrobial agent antibiotic,antibiotics,Antibiotika,Antibiotikum,antibiotique,antimicrobial,antimicrobial agents,microbicide,microbicides,Antimicrobial agent,antimicrobial agent
Group 0 name Corresponds to the control (unexposed) group for case-control studies
7 week old (young) mice before antibiotic treatment
Group 1 name Corresponds to the case (exposed) group for case-control studies
7 week old (young) mice 6 months after antibiotic treatments
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
7-week old mice (young mice) administered treated with broad-spectrum antibiotics metronidazole (500 mg/L) and ciprofloxacin (200 mg/L) for 10 days.
Group 0 sample size Number of subjects in the control (unexposed) group
5
Group 1 sample size Number of subjects in the case (exposed) group
5
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Mice were not previously given antibiotics before the study

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between young after 6 months of recovery

Abundance in Group 1: increased abundance in 7 week old (young) mice 6 months after antibiotic treatments

NCBI Quality ControlLinks
Romboutsia
Peptostreptococcaceae
Dubosiella

Revision editor(s): Gina

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between young after 6 months of recovery (lower panels)

Abundance in Group 1: decreased abundance in 7 week old (young) mice 6 months after antibiotic treatments

NCBI Quality ControlLinks
Clostridiales Family XIII bacterium
Candidatus Stoquefichus

Revision editor(s): Gina